Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Int J Parasitol. 2017 Sep 9;47(12):753–763. doi: 10.1016/j.ijpara.2017.08.006

Fig. 5.

Fig. 5

Metabolite identification. Adult BALB/c mice orally dosed with bumped kinase inhibitor (BKI) 1369 (60 mg/kg of body weight) yielded two major metabolites based on LC-MS/MS analysis of plasma samples. They were a product of the demethylation of the BKI 1369 methyl-piperidine-methyl group (metabolite 1) or a conversion of the quinoline ethyl ether to a 2-oxy-quinoline (metabolite 2). Each of the metabolites appears to be non-toxic to human cells.